Fiorella Colasuonno | Neuroscience | Women Researcher Award

Women Researcher Award

Fiorella Colasuonno — University of Rome Tor Vergata
Fiorella Colasuonno
Affiliation University of Rome Tor Vergata
Country Italy
Scopus ID 57196357192
Documents 15
Citations 2,581
h-index 8
Subject Area Neuroscience
Event World Science Awards
ORCID 0000-0002-4894-5084

Fiorella Colasuonno is a researcher in neuroscience whose published work has addressed cellular and molecular mechanisms associated with neurodegeneration, including riboflavin transporter deficiency, mitochondrial and peroxisomal dysfunction, induced pluripotent stem cell models, motor neurons, and neuronal cell-death mechanisms. Her research record includes work conducted through institutions in Rome and collaborations involving rare genetic and neuromuscular disease research. [1] [2]

Abstract

This academic recognition profile presents the research activities of Fiorella Colasuonno in the field of neuroscience. Her scholarly contributions include investigations of mitochondrial abnormalities, energy dysmetabolism, cytoskeletal organization, oxidative stress, induced pluripotent stem cell-derived neuronal models, and cellular mechanisms relevant to neurodegenerative disorders. Her publications have particularly examined riboflavin transporter deficiency and related motor-neuron pathology, while more recent work has extended to the study of cell death in induced pluripotent stem cell-derived cortical neurons as models of neurodegeneration. [1] [3] [4]

Keywords

Neuroscience; neurodegeneration; motor neurons; induced pluripotent stem cells; riboflavin transporter deficiency; mitochondrial dysfunction; peroxisomal alterations; cellular metabolism; cytoskeletal organization; rare genetic diseases; cortical neurons; cell death.

Introduction

Fiorella Colasuonno’s research is situated at the intersection of cellular biology, neuroscience, and rare-disease research. Available scholarly records associate her work with the University of Rome Tor Vergata and earlier research affiliations with the University of Roma Tre and the IRCCS Ospedale Pediatrico Bambino Gesù in Rome. Her doctoral research involved induced pluripotent stem cells and rare genetic diseases, including motor-neuron and neurometabolic disorders. [2]

Her published research provides a scientific basis for examining how metabolic, mitochondrial, peroxisomal, and structural cellular abnormalities may contribute to neurological disease. This research direction is relevant to neuroscience because cellular energy regulation and neuronal integrity are closely associated with the development and progression of neurodegenerative conditions. [3]

Research Profile

Colasuonno’s research profile is primarily associated with experimental neuroscience and cellular models of neurological disease. Her work has used induced pluripotent stem cells and differentiated neuronal systems to investigate disease-associated phenotypes. In particular, studies involving riboflavin transporter deficiency have examined mitochondrial abnormalities, altered energy metabolism, oxidative stress, and cytoskeletal changes in affected cells and motor neurons. [1] [3] [5]

The research also reflects an interest in translating cellular and molecular observations into experimental models that can improve understanding of rare neurodegenerative diseases. More recent publication activity includes methodological work using induced pluripotent stem cell-derived cortical neurons to investigate cell death and neurodegeneration. [6]

Research Contributions

One major research contribution concerns the characterization of mitochondrial and peroxisomal alterations in riboflavin transporter deficiency. Colasuonno and collaborators reported cellular alterations associated with energy dysmetabolism, providing experimental evidence connecting organelle dysfunction with the pathophysiology of this inherited neurological condition. [3]

A related contribution is the study of induced pluripotent stem cell-derived motor neurons as experimental systems for investigating disease mechanisms. Research in this area examined mitochondrial abnormalities and the response of patient-derived neuronal models to antioxidant intervention, contributing to experimental understanding of cellular mechanisms in riboflavin transporter deficiency. [1] [4]

Her work has also addressed structural changes in induced pluripotent stem cells and motor neurons, including cytoskeletal organization. Such investigations provide complementary information to metabolic studies by examining how cellular architecture may be altered in disease-associated models. [5]

Publications

Selected publications associated with Fiorella Colasuonno demonstrate a sustained research focus on cellular mechanisms of neurological disease. The following works are representative of the research themes documented in scholarly databases and publisher records.

Research Impact

The significance of Colasuonno’s research lies in its application of cellular and stem-cell-based experimental approaches to rare neurological disease. Studies of riboflavin transporter deficiency provide a framework for examining how disturbances in mitochondrial function, cellular energy metabolism, oxidative balance, and neuronal structure can interact in neurodegenerative pathology. [1] [3]

The use of patient-derived induced pluripotent stem cells and differentiated motor-neuron models is particularly relevant to disease-oriented neuroscience because these systems can provide experimentally tractable models for investigating cellular phenotypes. Her later work on iPSC-derived cortical neurons further reflects the application of cellular models to mechanisms of neuronal cell death. [4] [6]

Award Suitability

Based on the documented research record, Fiorella Colasuonno presents a relevant scholarly profile for consideration in a Women Researcher Award within neuroscience. Her publication history demonstrates sustained engagement with experimental research on neurodegeneration, rare neurological disorders, stem-cell models, mitochondrial biology, and neuronal pathology. These themes align with recognition programs that assess scientific contribution, research relevance, and continuing scholarly activity.

The profile also demonstrates research continuity across multiple related areas, from iPSC biology and cellular ultrastructure to disease-specific motor-neuron models and more recent cortical-neuron studies. [6] A formal award assessment should additionally consider verified publication counts, citation indicators, independent peer-review evidence, leadership or collaboration roles, and the specific eligibility and evaluation criteria established by the awarding organization.

Conclusion

Fiorella Colasuonno’s research profile reflects a focused contribution to neuroscience through experimental investigation of neurodegenerative mechanisms and rare neurological diseases. Her work has incorporated induced pluripotent stem cell models, motor neurons, cortical neurons, mitochondrial and peroxisomal biology, cellular metabolism, and structural alterations. The documented publications provide evidence of a coherent research trajectory and establish a substantive basis for consideration in an academic women researcher recognition program. [1] [3] [6]

References

    1. Colasuonno, F., Bertini, E., Tartaglia, M., Compagnucci, C., & Moreno, S. (2020). Mitochondrial Abnormalities in Induced Pluripotent Stem Cells-Derived Motor Neurons from Patients with Riboflavin Transporter Deficiency. Antioxidants, 9(12), 1252.
      DOI: https://doi.org/10.3390/antiox9121252
      PubMed record

Jiangang Duan | Neuroscience | Best Researcher Award

Prof. Jiangang Duan | Neuroscience | Best Researcher Award

Chief Physician at Xuanwu Hospital, Capital Medical University, China

Dr. Jiangang Duan is a distinguished neurologist and researcher at the Department of Emergency and Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. With over two decades of clinical and academic experience, he specializes in cerebral venous thrombosis (CVT), ischemic stroke, and neuroprotective therapies. His groundbreaking work includes the development of diagnostic imaging techniques, exploration of biomarkers for venous infarcts, and innovative non-drug therapies for ischemic stroke. Dr. Duan is also a dedicated mentor and educator, shaping the next generation of neurologists through his teaching and supervision of postgraduate students. His extensive research has been published in prestigious journals, and he has contributed to the creation of national guidelines for the management of cerebrovascular diseases.

Professional Profile

Education

Dr. Duan holds a Ph.D. and M.D. in Neurology from West China Hospital, Sichuan University (2004–2007), where his dissertation focused on the neuroprotective effects of acupuncture in ischemic stroke models. He earned an M.S. in Human Anatomy and Histoembryology from West China College of Basic and Forensic Medicine (2001–2004), researching ganglioside GM1’s role in neural stem cell differentiation. His academic journey began with a B.S. in Clinical Medicine from Inner Mongolia Medical College (1991–1996), establishing a strong foundation for his future contributions to neuroscience.

Professional Experience

Dr. Duan is an Associate Professor at the Department of Emergency and Neurology, Capital Medical University, Beijing, since 2015. His clinical and research roles involve pioneering treatment strategies for CVT and ischemic strokes. He previously served as a visiting scholar at the Chinese University of Hong Kong (2012–2013), contributing to long-term studies on cardiovascular risks in diabetic patients. Dr. Duan’s work at Xuanwu Hospital includes innovative projects like using DOACs for CVT treatment, evaluating glucocorticoid efficacy, and exploring NF-κB-NLRP3 inflammasome signaling in thrombosis pathogenesis. His efforts have significantly influenced the field of cerebrovascular disease management in China and beyond.

Research Interests

Dr. Duan’s research primarily focuses on the mechanisms and treatments of cerebrovascular disorders, particularly CVT and ischemic strokes. His interests extend to the role of inflammation in thrombosis, novel non-drug therapies for neuroprotection, and the efficacy of anticoagulants like Dabigatran in CVT management. He also investigates biomarkers, such as serum Claudin-5, for predicting venous infarcts and utilizes advanced imaging techniques like MRBTI to evaluate thrombosis stages. His translational research bridges clinical and preclinical studies, aiming to improve diagnostics, treatments, and outcomes for patients with cerebrovascular diseases.

Research Skills

Dr. Duan is proficient in advanced diagnostic imaging methods, including MRBTI, and skilled in conducting both retrospective and prospective studies. He excels in randomized controlled trials, having evaluated the safety and efficacy of anticoagulants and glucocorticoids in cerebrovascular diseases. His expertise in biomarker identification and inflammasome signaling pathways demonstrates his command of molecular and clinical neurology. Additionally, Dr. Duan is adept at statistical analysis, multidisciplinary collaboration, and guideline development, making him a leading figure in cerebrovascular research and clinical practice.

Honors and Awards

Dr. Duan has received numerous accolades, including the prestigious Chinese Medical Science and Technology Award (2019) for his work on non-drug therapies for ischemic stroke. In 2018, he was awarded a fellowship by the European Stroke Research Foundation, where he presented groundbreaking research at the 27th European Stroke Conference in Athens, Greece. He was also recognized with the Outstanding Mentor Management Award in 2021 for his exemplary guidance of postgraduate students. Earlier honors include a scholarship for master’s students at Sichuan University (2002–2003) and recognition for his contributions to cerebrovascular disease management guidelines in China.

Conclusion

Dr. Jiangang Duan is a strong contender for the Best Researcher Award. His robust track record in neurology research, impactful mentorship, and contributions to clinical practice guidelines highlight his expertise and dedication. While there is room to amplify his global impact through high-impact publications and leadership in international projects, his achievements already position him as a distinguished researcher in his field.

Publication Top Notes

  1. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial
    Authors: Ma, H., Gu, Y., Bian, T., Ji, X., Duan, J.
    Journal: International Journal of Stroke
    Year: 2024
    Volume & Pages: 19(6), pp. 635–644
    Citations: 2
  2. Multicenter registry study of cerebral venous thrombosis in China (RETAIN-CH): Rationale and design
    Authors: Bian, H., Wang, X., Liu, L., Wang, L., Ji, X.
    Journal: Brain and Behavior
    Year: 2024
    Volume & Pages: 14(4), e3353
  3. Night shift work was associated with functional outcomes in acute ischemic stroke patients treated with endovascular thrombectomy
    Authors: Yu, W., Ma, J., Guo, W., Zhao, W., Ji, X.
    Journal: Heliyon
    Year: 2024
    Volume & Pages: 10(4), e25916
  4. Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio
    Authors: Yu, W., Jia, M., Guo, W., Song, H., Ji, X.
    Journal: Current Neurovascular Research
    Year: 2024
    Volume & Pages: 21(1), pp. 6–14
  5. Severe deep cerebral venous thrombosis associated with ulcerative colitis: one case report | 重 症 脑 深 静 脉 血 栓 形 成 并 溃 疡 性 结 肠 炎 一 例
    Authors: Wang, J.-B., Gu, Y.-Q., Duan, J.-G.
    Journal: Chinese Journal of Contemporary Neurology and Neurosurgery
    Year: 2024
    Volume & Pages: 24(3), pp. 193–198
  6. Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis
    Authors: Guo, W., Li, N., Xu, J., Zhao, W., Ji, X.
    Journal: Journal of Clinical Pharmacy and Therapeutics
    Year: 2024
    Volume & Pages: Article ID: 1171260
  7. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
    Authors: Scutelnic, A., van de Munckhof, A., Krzywicka, K., Levi, M., van Gorp, E.C.M.
    Journal: European Stroke Journal
    Year: 2023
    Volume & Pages: 8(4), pp. 1001–1010
    Citations: 1
  8. Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis
    Authors: Liu, L., Zhou, C., Jiang, H., Zhou, C., Ji, X.
    Journal: Thrombosis Journal
    Year: 2023
    Volume & Pages: 21(1), Article 78
    Citations: 1
  9. Impaired Dynamic Cerebral Autoregulation in Patients With Cerebral Venous Sinus Thrombosis: Evaluation Using Transcranial Doppler and Silent Reading Stimulation
    Authors: Chen, S., Chen, H., Duan, J., Liu, R., Xing, Y.
    Journal: Ultrasound in Medicine and Biology
    Year: 2023
    Volume & Pages: 49(10), pp. 2221–2226
  10. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
    Authors: van de Munckhof, A., Borhani-Haghighi, A., Aaron, S., Ferro, J.M., Coutinho, J.M.
    Journal: International Journal of Stroke
    Year: 2023
    Volume & Pages: 18(9), pp. 1112–1120
    Citations: 3